Literature DB >> 55650

Menstrual blood-loss with intrauterine devices.

J Guillebaud, J Bonnar, J Morehead, A Matthews.   

Abstract

The effect of three intrauterine contraceptive devices (I.U.D.)-Lippes D, Dalkon Shield, and Copper 7-on menstrual blood-loss has been studied serially by objective methods in 279 women. All the women had a minimum of two cycles following delivery, abortion, cessation of lactation, or previous pill or I.U.D. use. All pads and tampons used for two further menstrual cycles before and for 12 cycles after I.U.D. insertion were collected, and the blood-loss was measured by extracting the haemoglobin by conversion to alkaline haematin. Mean menstrual blood-loss increased with all three devices. The amount of loss, the percentage of women losing more than 80 ml, the decline in haemoglobin concentration, and the incidence of anaemia during the 12 cycles following insertion were all greater among users of the Lippes Loop than of the Copper 7 with generally intermediate values for Dalkon Shield users. The mean increases in blood-loss were: for parous women fitted with the Lippes Loop, 48 ml, with the Dalkon Shield, 34 ml, and with the Copper 7, 18 ml; for nulliparae fitted with the small size of Dalkon Shield, 27 ml, and, with the Copper 7, 19 ml.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 55650     DOI: 10.1016/s0140-6736(76)90216-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Effect of intrauterine devices on menstrual blood loss.

Authors:  J Gao; S Zeng; L Y Ma; H M Fan; X L Hu; L H Han
Journal:  Acta Acad Med Wuhan       Date:  1984

2.  Effect of norethisterone on puerperal vaginal bleeding.

Authors:  H M Murphy
Journal:  Ir J Med Sci       Date:  1980-11       Impact factor: 1.568

Review 3.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

4.  Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment.

Authors:  N Milman; M Kirchhoff; T Jørgensen
Journal:  Ann Hematol       Date:  1992-08       Impact factor: 3.673

Review 5.  Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use.

Authors:  D A Grimes; D Hubacher; L M Lopez; K F Schulz
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

6.  Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.

Authors:  Ashley S Felix; Mia M Gaudet; Carlo La Vecchia; Christina M Nagle; Xiao Ou Shu; Elisabete Weiderpass; Hans Olov Adami; Shirley Beresford; Leslie Bernstein; Chu Chen; Linda S Cook; Immaculata De Vivo; Jennifer A Doherty; Christine M Friedenreich; Susan M Gapstur; Dierdre Hill; Pamela L Horn-Ross; James V Lacey; Fabio Levi; Xiaolin Liang; Lingeng Lu; Anthony Magliocco; Susan E McCann; Eva Negri; Sara H Olson; Julie R Palmer; Alpa V Patel; Stacey Petruzella; Jennifer Prescott; Harvey A Risch; Lynn Rosenberg; Mark E Sherman; Amanda B Spurdle; Penelope M Webb; Lauren A Wise; Yong-Bing Xiang; Wanghong Xu; Hannah P Yang; Herbert Yu; Anne Zeleniuch-Jacquotte; Louise A Brinton
Journal:  Int J Cancer       Date:  2014-09-30       Impact factor: 7.316

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.